Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$110.31 - $140.45 $772 - $983
7 Added 0.36%
1,976 $224,000
Q1 2024

May 09, 2024

BUY
$114.22 - $140.1 $114 - $140
1 Added 0.05%
1,969 $273,000
Q4 2023

Feb 07, 2024

SELL
$75.49 - $124.16 $147,130 - $241,987
-1,949 Reduced 49.76%
1,968 $244,000
Q3 2023

Nov 07, 2023

SELL
$86.06 - $137.93 $42,341 - $67,861
-492 Reduced 11.16%
3,917 $365,000
Q2 2023

Aug 07, 2023

SELL
$112.47 - $130.98 $9,447 - $11,002
-84 Reduced 1.87%
4,409 $566,000
Q1 2023

May 03, 2023

SELL
$104.0 - $122.92 $21,424 - $25,321
-206 Reduced 4.38%
4,493 $521,000
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $62,715 - $90,530
738 Added 18.63%
4,699 $532,000
Q3 2022

Nov 09, 2022

BUY
$76.35 - $94.18 $5,649 - $6,969
74 Added 1.9%
3,961 $319,000
Q2 2022

Aug 03, 2022

BUY
$67.99 - $132.89 $190,236 - $371,826
2,798 Added 256.93%
3,887 $290,000
Q1 2022

Apr 20, 2022

BUY
$94.08 - $130.2 $15,617 - $21,613
166 Added 17.98%
1,089 $557,000
Q4 2021

Jan 21, 2022

BUY
$129.87 - $162.82 $2,207 - $2,767
17 Added 1.88%
923 $495,000
Q3 2021

Oct 29, 2021

SELL
$106.71 - $143.18 $2,987 - $4,009
-28 Reduced 3.0%
906 $495,000
Q2 2021

Aug 02, 2021

BUY
$80.99 - $107.93 $75,644 - $100,806
934 New
934 $399,000
Q1 2021

Apr 29, 2021

SELL
$84.79 - $104.74 $44,006 - $54,360
-519 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $3,354 - $4,493
-43 Reduced 7.65%
519 $192,000
Q3 2020

Nov 03, 2020

SELL
$95.51 - $112.95 $286 - $338
-3 Reduced 0.53%
562 $232,000
Q2 2020

Jul 27, 2020

BUY
$62.68 - $105.34 $35,414 - $59,517
565 New
565 $229,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Pinnacle Wealth Planning Services, Inc. Portfolio

Follow Pinnacle Wealth Planning Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.